Apr 29, 2023 08:00 AM
Beijing Hotgen Biotech Co.,Ltd.’s Net Profit Dropped 58% in 2022
00:00/00:00
Listen to this article
1x
Subscribe now
Listen to the full version
Listen to the full version
Beijing Hotgen Biotech Co.,Ltd. (北京热景生物技术股份有限公司) (688068.SH) reported a net profit of 925.1 million yuan in 2022, down 58% year-on-year.
Meanwhile, the company posted 3.6 billion yuan in revenue, down 33.8% year-on-year.
At the end of the reporting period, it had 3.9 billion yuan in total assets and 545.6 million yuan in total liabilities, with a liability-to-asset ratio of 14%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Save an extra $50. Introductory offer for new readers. Subscribe now.
Share this article
Open WeChat and scan the QR code
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新